Award
National Institute on Drug Abuse 11238494
Identifying optimal buprenorphine dosing for OUD treatment and prevention of overdose
Recipient
Not specified
Award Amount
$508,750.00
Ceiling
$508,750.00
Awarded
February 18, 2026
Identifier
11238494
Award for a study and trial to find the best buprenorphine dosing for opioid use disorder treatment, especially for patients using fentanyl.
Description
This project involves a mixed-method study and a randomized controlled trial to determine optimal buprenorphine dosing for opioid use disorder treatment, focusing on patients with fentanyl use. The project is funded by the National Institute on Drug Abuse (NIDA).